Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Citation Tools

Extended report

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hoekstra M, van Ede AE, Haagsma CJ, et al

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases 2003;62:423-426.